JENNIFER WOODFORD: Open Payments
NPI 1720366982 · VESTAL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,239 in 121 payments from 18 companies in 2025. Trend: 2023 $2,319 · 2024 $2,442 · 2025 $2,239
Food & beverage: $2,059Education: $180
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $447 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $305 |
| Incyte Corporation | 12 | $275 |
| Novartis Pharmaceuticals Corporation | 15 | $231 |
| GENZYME CORPORATION | 12 | $222 |
| Janssen Biotech, Inc. | 13 | $192 |
| Regeneron Healthcare Solutions, Inc. | 3 | $115 |
| E.R. Squibb & Sons, L.L.C. | 4 | $102 |
| PFIZER INC. | 4 | $87 |
| LEO Pharma Inc. | 3 | $68 |
Products named: DUPIXENT, OPZELURA, SKYRIZI, RINVOQ, TREMFYA, COSENTYX, ILUMYA, Sotyktu.
Industry payments across NY — which companies pay providers there.
